• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2400181 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs License Renew 2024-07-05 view
JYHZ2400180 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs License Renew 2024-07-05 view
JYHZ2400179 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs License Renew 2024-07-05 view
JYHZ1900233 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs License Renew 2019-09-02 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2020-05-09 view
JYHZ1900232 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs License Renew 2019-09-02 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2020-05-09 view
JYHZ1900231 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs License Renew 2019-09-02 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2020-05-09 view
JYHS2400054 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs(5.2) Import Drug Application 2024-10-30 view
JYHS2400053 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs(5.2) Import Drug Application 2024-10-30 view
JYHS2300110 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs(5.2) Import Drug Application 2023-08-29 view
JYHS2300109 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs(5.2) Import Drug Application 2023-08-29 view
JYHS2300108 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs(5.2) Import Drug Application 2023-08-29 view
JYHS2300024 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs(5.2) Import Drug Application 2023-02-18 view
JYHS2300023 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs(5.2) Import Drug Application 2023-02-18 view
JYHB2100126 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2021-02-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-02-05 view
JYHB2100125 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2021-02-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-02-05 view
JYHB2100124 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2021-02-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-02-05 view
JYHB2001449 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2020-08-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Filed 2020-09-02 view
JYHB2001448 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2020-08-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Filed 2020-09-02 view
JYHB2001447 沙美特罗替卡松吸入粉雾剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2020-08-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Filed 2020-09-02 view
JYHB1601435 沙美特罗替卡松粉吸入剂 fluticasone propionate;salmeterol xinafoate Inhalation Chemical Drugs Supplementary Application 2016-11-16 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2017-06-09 view